Differin
Epiduo Acne Treatment Gel - 1.6 oz
Serum – for Acne & breakouts
$42.9947.3ml · $0.91/ml
Ideal for
- ExcellentAcne & breakouts
- ExcellentBlackheads
- StrongPost-acne marks
- StrongDryness
Not recommended for
Differin
Epiduo Acne Treatment Gel - 1.6 oz
Serum – for Acne & breakouts
$42.9947.3ml · $0.91/ml
Ideal for
- ExcellentAcne & breakouts
- ExcellentBlackheads
- StrongPost-acne marks
- StrongDryness
Not recommended for
Product Score
Breakdown of key factors contributing to this product match
Research Score
100%
41 scientific studies support the efficacy of this product's ingredients. 100% is the strongest evidence we typically find in a retinoid treatment for concerns like yours.
Consumer Reviews
70%
Based on 36 customer reviews (4.6★). Mixed feedback from users with similar profiles.
Targets Your Concerns
Product Ingredients (7)
Review of how moisturizers affect the epidermal barrier: humectants such as glycerin increase stratum corneum hydration and can strengthen barrier function and resistance to irritation, although effects depend on formulation and some moisturizers may weaken the barrier; supports well-formulated glycerin-containing emollients for dry, barrier-impaired skin.
Review establishing glycerin as the gold standard humectant: attracts water to stratum corneum via hydrogen bonding, improves skin mechanical properties (elasticity, pliability), enhances desmosome degradation for smooth desquamation, and modulates aquaporin-3 channels; effective at 2-20% in topical formulations
Comprehensive review of moisturization mechanisms: glycerin contributes to corneocyte hydration by replacing lost natural moisturizing factor (NMF) components; maintains stratum corneum fluidity at low humidity; superior humectant performance vs propylene glycol, sorbitol, and urea in controlled comparisons
0.3% adapalene achieved superior reduction in inflammatory and non-inflammatory lesions vs 0.1%, with acceptable tolerability.
Meta-analysis: Meta analysis of five RCTs confirming adapalene class effect.
Randomized controlled trial (n=653, 12 weeks): Pivotal adapalene 0.3 vs 0.1 vs vehicle phase 3.
Randomized controlled trial (n=609, 12 weeks): Replicates Mills 1986 finding in Asian skin with larger n; 72.7% vs 75.0% vs 41.7% lesion reduction 2.5 vs 5 vs placebo.
Comparable acne reduction to tretinoin with significantly less irritation, dryness, and erythema.
Systematic review: Current evidence synthesis confirming BPO efficacy for acne moderate certainty of evidence.
Randomized controlled trial (n=153, 8 weeks): Efficacy equivalence across concentrations with tolerability advantage for 2.5%.













